Skip to main content
. Author manuscript; available in PMC: 2016 Aug 12.
Published in final edited form as: N Engl J Med. 2012 Aug 16;367(7):595–605. doi: 10.1056/NEJMoa1201637

Table 1.

Base, favorable (fav.) and unfavorable (unfav.) utility estimates and durations for each health state.

Health state Utility estimate Source of utility
estimate
Duration Source of duration
base fav. unfav.
Screening attendance 0.99 1 0.99 17, 30 1 week Assumption
Biopsy 0.90 0.94 0.87 30 3 weeks Assumption
Diagnosis 0.80 0.85 0.75 based on43 1 month Assumption
Radiation therapy (RT) 0.73 0.91 0.71 19 2 months 19
Radical prostatectomy (RP) 0.67 0.9 0.56 19 2 months 19
Active surveillance 0.97 1 0.85 4446 7 years 47
2 months – 1 year RT 0.78 0.88 0.61 48 10 months 18
2 months – 1 year RP 0.77 0.91 0.70 49 10 months 18
Post-recovery period 0.95 1 0.93 18, 19 9 years* Assumption
Palliative therapy 0.60 0.24 0.86 5053 30 months 54
Terminal illness 0.40 0.24 0.40 50, 52, 53 6 months 52, 53
*

The duration of the post-recovery period used for the sensitivity analysis was the residual life-time38